NeoTract, Inc. UroLift ATC® System (1 Box = 1 Cartridge. Minimum Order = 1 Box
The UroLift ATC® System (UL400ATC) by NeoTract, Inc. is a minimally invasive device designed for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The system utilizes a cartridge-based delivery mechanism to deploy small implants that hold the enlarged prostate tissue away from the urethra, thereby relieving obstruction and improving urine flow. Each box contains one cartridge, and the minimum order quantity is one box. The UroLift ATC System is intended for use by trained urologists in a clinical setting and is part of NeoTract's portfolio of BPH treatment solutions. The device is designed to provide rapid symptom relief and preserve sexual function, with a well-established safety and efficacy profile supported by clinical studies.
